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Abstract
Author Manuscript

Metabolomics aims to provide a global snapshot of all small-molecule metabolites in cells and
biological fluids, free of observational biases inherent to more focused studies of metabolism.
However, the staggeringly high information content of such global analyses introduces a challenge
of its own; efficiently forming biologically relevant conclusions from any given metabolomics
dataset indeed requires specialized forms of data analysis. One approach to finding meaning in
metabolomics datasets involves multivariate analysis (MVA) methods such as principal
component analysis (PCA) and partial least squares projection to latent structures (PLS), where
spectral features contributing most to variation or separation are identified for further analysis.
However, as with any mathematical treatment, these methods are not a panacea; this review
discusses the use of multivariate analysis for metabolomics, as well as common pitfalls and
misconceptions.
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Introduction
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Metabolomics is defined [1] as “the quantitative measurement of the multiparametric
metabolic response of living systems to pathophysiological stimuli or genetic modification.”
Such a definition implies that metabolomic studies offer the finest-grained detail available in
the nascent field of systems biology: a molecular-level convolution of all upstream genomic,
transcriptomic and proteomic responses of an organism to a given stimulus or change [2-4].
Metabolites are the end product of all cellular processes, and are a direct outcome of
enzymatic and protein activity. Thus, metabolites are more proximal to a phenotype or
disease than either genetic or proteomic information [5, 6]. This occurs because a simple
change in the expression level of a gene or protein does not necessarily correlate directly
with a variation in the activity level of a protein, but an alteration in a metabolite only occurs
through such a change [7]. Consequently, metabolomics has been used to identify disease
biomarkers [8, 9], to aid in the drug discovery process [10, 11], and to study plants [12],
bacteria [13, 14], nutrition [15], and the environment [16], among numerous other
applications [17].
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However, metabolomics experiments are plagued with difficulty. The number of smallmolecule metabolites in a biofluid, cell lysate, tissues or organ differs wildly depending on
the organism studied, ranging from several hundred to hundreds of thousands [18].
Metabolomics is also a relatively new discipline and as a result a complete catalog of the
human metabolome and the metabolomes of other organisms is not available [19].
Therefore, it is common to encounter unknown metabolites, a complication in the analysis
and interpretation of metabolic changes. Similarly, the lack of reference NMR or MS spectra
for all known metabolites makes proper identification of metabolites challenging [20-22].
Further, the exhibited diversity of chemical and physical properties of compounds within the
metabolome makes true metabolomics (simultaneous quantification of all metabolites)
unattainable with current instrumental capabilities [1, 18, 23]. As an illustration, the limited
molecular-weight distribution of the metabolome prohibits a comprehensive and detailed
analysis by mass spectroscopy and generally requires the additional use of chromatography
[2, 24].

Author Manuscript

The analysis of metabolomic data is further complicated by the inherent variability in each
sample. Every single cell, tissue, organ or organism is fundamentally unique [25], despite
any defining feature they share in common, such as being the same species, infected with the
same disease or receiving the same drug treatment. As such, the overall goal of
metabolomics is to identify the few chemical features against a large and complex
background of metabolites that uniquely define the system [20, 26]. These few chemical
features or metabolites should be directly related to the defining characteristic of the system.
But, unfortunately, all biological systems are easily perturbed by any number of
experimental or environmental factors, such as age, diet, growth phase, media, nutrients, pH,
sex, and temperature [27, 28]. Similarly, cell lysis, enzyme quenching and metabolome
extraction techniques, and the storage of the metabolomics samples can also induce
undesirable variations. There are also unavoidable fluctuations in spectral data, such as
changes in peak position or peak width that are caused by instrument instability and
variability in sample conditions. As a result, the analysis of metabolomic data requires a
robust methodology to expose underlying trends in these highly complex and variable data
sets.
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One class of methods, appropriately termed “metabolic fingerprinting,” aims to retain much
of the promised unbiased, global nature of the metabolomics experiment by differentially
analyzing spectral information acquired from normal and perturbed systems [29]. Again, a
perturbed system may result from a disease state, a drug treatment, the presence of a pest or
parasite, an environmental stimulus (pH, temperature, toxin, or nutrient change), a temporal,
spatial, or species difference. Metabolic fingerprinting is also amenable to high throughput
data collection and analysis, since global metabolite profiling can be accomplished with
minimal samples and rapid spectral acquisitions [30]. The goal of metabolic fingerprinting
experiments is to determine the relative differences between the metabolomes of two or
more systems to infer a biological relationship. Thus, a hallmark of metabolic fingerprinting
is the use of multivariate analysis methods to identify those biologically relevant spectral
features for further targeted analyses [1, 23, 31], with two of the most popular methods
being principal component analysis (PCA) [32, 33] and partial least squares projection to
latent structures (PLS) [34, 35]. In essence, PCA and PLS aim to differentiate between
Curr Metabolomics. Author manuscript; available in PMC 2015 June 13.
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classes in highly complex data sets, despite within class variability. These multivariate
analysis methods will be briefly described, along with a discussion of their application to
metabolomics, with an emphasis on common errors and misconceptions.
Metabolomics datasets
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The choice of analytical method used for metabolic fingerprinting experiments is limited
primarily by its ability to reveal metabolic differences due to system perturbations. Other
desirable features include minimal sample preparations or requirements, and the ability to
analyze the samples in a high-throughput manner. High-resolution 1H NMR spectroscopy is
especially suited for probing biofluids, cell lysates and tissues with almost no sample
treatment and without bias [36, 37]. Mass spectrometry is similarly employed for metabolic
fingerprinting and is typically favored for its sensitivity in more global metabolic profiling
applications, but generally requires upstream chromatographic separations due to the limited
molecular-weight diversity of metabolites [37-39]. Raman and Fourier-transform infrared
(FT-IR) spectroscopies have also been successfully utilized [31, 40] for metabolomic
studies, and capillary electrophoresis has recently been shown to provide useful data [41, 42]
in fingerprinting experiments.
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The remarkable diversity of instrumental approaches used in metabolic fingerprinting
experiments is traceable in large part to the flexibility of the multivariate analysis techniques
used to analyze the collected data. A data matrix X, containing N observation row vectors of
K variables each, is almost universally common [34, 43, 44], and very few mathematical
constraints are placed on the values it holds. Correspondingly, NMR, MS, FT-IR, or any
other source of spectral data can be used as input into the data matrix X. However, as
discussed below, preprocessing of the data matrix is essential to yield interpretable results.
This data matrix X can be immediately decomposed using unsupervised dimensionality
reduction methods, such as PCA, or it can be paired with a matrix Y of N corresponding Mdimensional outputs for use in supervised dimensionality reduction, in the case of PLS
regression (PLSR) and its descendants. An output may range from a simple class
membership designation [35] to a range of observables [45], such as patient histories (age,
sex, weight, etc.). While the same mathematical flexibility also applies to outputs, metabolic
fingerprinting data typically stores binary (or n -ary) class membership information in Y, in
which case the applicable supervised methods are forms of discriminant analysis (PLS-DA,
OPLS-DA). A graphical representation of the data (X) and response (Y) matrices, along with
their PCA/PLS decomposition, is shown in Figure 1.
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Simply, the primary goal of PCA and PLS is to identify class differences from a multivariate
dataset. A class can refer to any biologically relevant classification, such as humans treated
with a specific diet or drug; or cells exposed to particular environmental stress (temperature,
pH, osmolality, etc.), or different genetic modification to an organism. An NMR, MS, or FTIR spectrum of a biofluid or metabolome extract is an observation: a vector of K variables,
where each spectrum represents an individual cell culture, tumor or organism. The entire
collection of N observations forms the data matrix X. PCA and PLS then identify a
combination of the K variables or spectral features that defines the class separation.
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A key characteristic of metabolic fingerprinting datasets is an excess of observed variables
(K) in comparison to the number of observations (N), belonging to the so-called ‘large K,
small N’ class of problems in statistics [46]. This feature makes traditional linear regression
methods infeasible, as X is no longer invertible (i.e. it is singular) and no unique leastsquares solution exists. Consequently, analysis of metabolomics data requires the use of
multivariate analysis methods capable of dealing with significant amounts of collinearity in
X, of which PCA and PLS are prime examples.
Linear transformations
The ultimate goal of the multivariate dimensionality reduction algorithms discussed herein is
to find a K -by- P matrix A that optimally transforms the data matrix X into a new matrix of
P -dimensional scores given by T:
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[1]

Thus, each row of T is a transformation of the corresponding row of X. Alternately,
expressing the i -th row of X as a column vector xi and the corresponding row of T as a
column vector ti shows that the so-called ‘weights’ matrix AT defines a linear transformation
from the input data space occupied by X to the output space of T, termed the ‘scores’ space:

[2]
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In the case where P is less than K, the dimensionality of the scores space will be less than
that of the input data space and the above transformation has achieved dimensionality
reduction. This is a key characteristic of multivariate analysis in metabolic fingerprinting.
Finally, the optimal transformation by matrix A depends on the chosen algorithm, such as
PCA, PLS, or OPLS.
Principal Component Analysis
Principal component analysis (PCA) is arguably the most widely used multivariate analysis
method for metabolic fingerprinting and, in fact, chemometrics in general. The objective of
PCA is to arrive at a linear transformation that preserves as much of the variance in the
original data as possible in the lower dimensionality output data [44]. It can be shown [44]
that the transformation A that achieves this objective is a matrix whose columns are the first
P eigenvectors of the non-singular portion of the sample covariance matrix S:

Author Manuscript

[3]

Here, H is the N -by- N centering matrix used to center each variable about its sample mean.
The second equality above describes the form of the eigendecomposition of S, where Q is
the matrix of eigenvectors of S and Λ is a diagonal matrix of the corresponding eigenvalues.
When X is left unscaled, the eigenvalues in Λ equal the variances of the newly transformed
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data in T, providing a means to calculate the ratio of variance preserved during the
transformation relative to the original variance:

[4]

Where
is the amount of variance in X preserved in the i -th principal component. Given
the fact that Λii decreases monotonically with i, it can be seen that each principal component
preserves progressively less variance of the original data.
Partial Least Squares

Author Manuscript

While the unsupervised nature of the PCA algorithm provides a means to achieve unbiased
dimensionality reduction, its application only reveals group structure when within-group
variation is sufficiently less than between-group variation. Therefore, supervised forms of
discriminant analysis such as Partial Least Squares (PLS-DA; alternatively Partial Least
Squares Projections to Latent Structures [35]) that rely on the class membership of each
observation are also commonly applied in metabolic fingerprinting experiments [35, 47].
When class memberships are coded in matrix form into Y [47] and the PLS components are
constrained to be orthogonal, the dimensionality-reducing transformation A is a matrix
whose columns are the first P eigenvectors of a matrix formed by the covariances between X
and Y:

[5]
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Where H is again the centering matrix and the eigendecomposition takes an identical form
to that shown for PCA. Thus, the new ‘latent variables’ formed by this transformation are
linear combinations of original variables that preserve as much covariance between X and Y
as possible in the first transformed dimensions; simply put, the low-dimensional scores
space is formed predominately by the predictive components of X. This casting of PLS-DA
as an eigendecomposition problem [48] is of course, complementary to the usual description
of the algorithm as an iterative regression problem that more closely resembles the roots of
PLS regression [34, 35]. However, it provides a means to contrast the results of PLS-DA
with those of PCA. In fact, placing every observation into its own class, effectively setting Y
to the identity, yields an identical eigenvector problem to that of PCA.
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It is far more common, however, to find descriptions of PLS-DA that do not impose
orthogonality of the PLS components; these methods require instead that the X scores be
uncorrelated, closer to traditional PLS regression [35]. The popular form of PLS-DA under
this condition is then:

[6]

Curr Metabolomics. Author manuscript; available in PMC 2015 June 13.

Worley and Powers

Page 6

Author Manuscript

[7]

Where T and P are the scores and loadings for X, U and C are the scores and loadings for Y,
and E and G are the residual errors of X and Y that are left unaccounted for in the model.
Decomposition is performed such that T and U share maximum covariance, in effect
allowing T to serve as an estimator of U. These equations emphasize the fact that PLS finds
a small set of scores and loadings – the latent structures – which most effectively summarize
X and Y as well as describe their correlation. Until recently, this traditional PLS regression
method was referred to as Partial Least Squares due to its use of Non-linear Iterative Partial
Least Squares (NIPALS) for estimating model parameters. With the introduction of PLS to
chemometrics, an alternative meaning of ‘Projection to Latent Structures’ has also been used
for the methods of Partial Least Squares regression [35].

Author Manuscript

Orthogonal Projection to Latent Structures
The utilization of class memberships in PLS-DA allows the algorithm to better expose
separations between classes in scores space. However, variation not directly correlated with
Y is still present in the scores. This complicates interpretation of PLS-DA scores and
loadings plots, especially as the number of classes increases [43]. Orthogonal Projections to
Latent Structures (OPLS) addresses this interpretability problem by incorporating an
Orthogonal Signal Correction (OSC) filter [49-51] into a PLS model, effectively separating
Y -predictive variation from Y -uncorrelated variation in X:

[8]
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Where To and Po are the scores and loadings, respectively, for the Y -uncorrelated variation
identified by the OSC filter. The predictive OPLS-DA scores and loadings used to estimate
Y are then composed of variation directly correlated with Y and free of interfering structured
variation, yielding enhanced interpretability when compared with PLS-DA [43, 52]. Finally,
it is important to note that OPLS-DA provides no predictive advantage over PLS-DA [53];
in fact, when no Y -uncorrelated variation exists in X, OPLS-DA will yield an identical
model to PLS-DA.

Method Selection

Author Manuscript

In designing experiments for metabolic fingerprinting studies, the choice of multivariate
analysis method must be driven by the data and the experimental goals. For exploratory
studies where metabolomic differences between experimental groups may be unknown or
unpredictable, initial application of PCA provides an informative first look at the dataset
structure and relationships between groups. Even when dataset structure may be predictable,
initial use of unbiased methods like PCA provide further confirmation prior to analysis by
supervised methods. Ideally, the results of PCA analyses would be used to formulate an
initial biological conclusion, which PLS or OPLS can then verify and test in more detail.
The principal reason for this is due to the fact that separation is only observed between
groups in PCA scores when within-group variation is significantly less than between-group
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variation in the data, while separation in PLS scores may simply be fortuitous. Therefore,
PLS classification guided by well-separated PCA scores has a greater likelihood of
producing biologically relevant results.
Data Preprocessing
Pre-treatment of raw spectral data is critical for generating reliable, interpretable models
using multivariate analysis techniques. A summarization of the procedures involved for
preprocessing of metabolic fingerprinting datasets has been well described, and efforts have
been made to standardize the processes [54, 55]. Nevertheless, depending on the
instrumental technique, the experimenter must adopt certain procedures to obtain an optimal
model.
Binning and alignment

Author Manuscript

The binning procedure not only masks subtle chemical shift differences and filters noise in
spectra, but it also hides potentially significant changes of low-intensity peaks nearby strong
signals. Unfortunately, uniform binning incurs the risk of splitting peaks or spectral features
between bins, recreating the imprecision in the X variables that the preprocessing set out to
correct. “Intelligent” or “adaptive” binning endeavors to evade this problem by using
variable bin sizes that avoid dividing peaks between multiple bins [56-59]. A recent kernelbased method of binning seeks to optimally reduce variable count while retaining spectral
information by applying a Gaussian weighting function [57]. Other adaptive binning
methods rely on a recursive algorithm [56], undecimated wavelet transforms [58] or the
optimization of an objective function using a dynamic programming strategy [59] to identify
bin edges. Regardless of the approach, adaptive binning performs significantly better than
uniform binning [59]. Alternatively, full-resolution spectral signals may be computationally
aligned within a dataset to remove chemical shift variability, retaining the possibility of
avoiding binning and performing multivariate analysis with less loss of spectral information
[60-65]. Spectral alignment has been accomplished using a variety of approaches that
includes fuzzy warping, genetic algorithms, a generalized fuzzy Hough transform approach,
a reduced set mapping (PARS) algorithm, or a recursive segment-wise peak alignment.
Importantly, spectral alignment was shown to improve upon the results obtained using
adaptive binning [65]. Sample acidification has also been used prior to data collection to
force peaks into alignment [66]. Finally, it has been demonstrated that OPLS-DA more

Author Manuscript
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As 1H NMR chemical shifts vary at times with a strong dependence on temperature, pH,
ionic strength, and other factors that influence their electronic environment, metabolic
fingerprinting datasets acquired from NMR spectrometers suffer from imprecisions in
chemical shifts, and thus in the X variables. Therefore, models generated using PCA or PLSDA on full-resolution 1H NMR spectra may fail to identify separations between classes, and
their loadings can be difficult to interpret due to the over-abundance of variables. These
complications from chemical shift variations may be mitigated by uniformly dividing each
spectrum into ‘bins’ having typical spectral widths of 0.04 ppm and integrating signal
intensities within each bin to produce a smaller set of variables. A representative example of
a binned 1H NMR spectrum is given in Figure 2, showing the appreciable loss of resolution
typically incurred.
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effectively copes with chemical shift variation in full-resolution 1H NMR datasets [67]
without requiring binning or alignment steps.
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A similar alignment problem arises in the retention times of chromatograms used in GC-MS
and LC-MS metabolomics experiments, where shifts in observed metabolite retention times
between samples can obscure true relationships in model loadings [68]. The use of
correlation optimized warping (COW), a specialized form of dynamic time warping (DTW),
has recently found success in bringing peaks in chromatographic datasets into alignment by
means of a dynamic programming algorithm [69, 70]. Methods of automated optimal
parameter selection for COW have also been introduced, reducing the amount of operator
intervention required for aligning large datasets [71]. Maven [72], MetaboAnalyst [73],
MZmine [74] and PolyAlign [75] are just a few examples of some popular alignment
software programs and metabolomics work-flow packages that are available. Some recent
alternatives to COW approach to peak alignment include model-base [76], density
maximization [77], fuzzy clustering [78] or maximum-likelihood [79].
Data normalization

Author Manuscript

To account for variable dilution factors of metabolic fingerprinting samples arising from
variations in the number of cells, biofluid volume or tissue size, each observation row in X
may be normalized to ensure that all observations are directly comparable. Normalization
may be accomplished internally by computational means using internal standards (e.g.
TMSP in NMR) [80, 81] or externally via measurements of cell culture optical density or
protein content. The simplest form of internal scaling, called constant-sum normalization, is
where each spectrum is normalized such that its integral is 1. While this accounts for
variable dilutions each sample may possess, it can mask truly biologically relevant changes
and obscure interpretation of loadings [80].
Data scaling

Author Manuscript

While the discussed forms of multivariate analysis are defined based on the covariance
eigenstructure of X and Y, practical considerations motivate the use of variable scaling prior
to analysis. From an intuitive standpoint, a linear combination of observations from different
instrumental sources – 1H NMR and MS, for example – has no physical meaning. However,
even when all variables bear identical units, highly disparate intensities and variances
between variables will force most forms of multivariate analysis to focus on a small set of
intense signals [44]. For these reasons, variables may be autoscaled to have zero mean and
unit variance through a z -scoring operation [80] that results in PCA and PLS examining
correlations, rather than covariances, in X and Y. Myriad other forms of scaling exist (Table
1), each of which enhance different features in the data and carry different disadvantages,
which may suit every metabolic profiling experiment differently [82]. Figure 3 shows the
results of applying unit variance autoscaling to a set of simulated two-peak NMR spectra.
Noise and baseline removal
A principal disadvantage of data scaling is its tendency to amplify instrumental noise, to
which PCA and PLS have been shown to be sensitive [52, 83]. Methods of scaling based on
Maximum Likelihood PCA (MLPCA) [84] have been used to estimate and remove
Curr Metabolomics. Author manuscript; available in PMC 2015 June 13.
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instrumental errors prior to multivariate analysis [85]. More simply, domain knowledge may
be used to preselect variables based on experimental relevance or noise criteria for the
removal of signal-free baseline noise from acquired spectra or the selection of more narrow
spectral regions [86].
Variable selection
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Due to the expense of sampling and data collection in metabolomics experiments, a
tendency exists in metabolic fingerprinting studies to retain all collected variables for
multivariate analysis [86]. Unfortunately, this exacerbates the aforementioned collinearity
problem and increases the likelihood of finding spurious correlations in data, leading to a
greater chance of inferring incorrect biological conclusions [46, 51]. While it is not typically
performed during data exploration, variable selection may be used conservatively in concert
with domain knowledge to select only biologically meaningful regions of datasets for
classification or dimensionality reduction. 1H NMR datasets, for instance, may contain
highly varying signals from solvents, buffers and chemical shift reference compounds, as
well as large signal-free noise regions. Both of these features may obscure biologically
relevant variation and are good candidates for variable selection/removal. Structured noise
(baseline issues, contaminants) negatively affects the correspondence between scores and
loadings and hinders the correct interpretation of PLS results [87]. OPLS can separate out
this structured noise, but often at the expense of an overly complex model [88]. There are
significantly more variables (K) than observations (N) in a typical metabolomics dataset, so
removing irrelevant variables is beneficial to the multivariate analysis. A more exhaustive
variable selection approach applies a pretreatment based on orthogonal projections [89] or a
recursive algorithm [90-92], support vector machine, genetic algorithm or random forest, to
select for variables or spectral features primarily contributing to class separation. This is
particularly pertinent to MS metabolomics data that may contain a very large number of
variables, of which only a small percentage is relevant. Importantly, either the complete
absence of variable selection or an overly aggressive variable selection may lead to
inadequate separation or over-fitting of the dataset, respectively [92, 93].

Author Manuscript

Interpretation
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Interpretation of multivariate analysis results of metabolic fingerprinting data for the
purposes of inferring biological importance must be done with care, bearing in mind the
nature and goal of the algorithm used. Scatter plots of scores and loadings are no exception,
particularly since different axis scaling can produce misleading results [86, 94]. As an
illustration, an observed difference in a scores plot comparing spectral data obtained from
healthy and ill patients may infer the existence of potential disease biomarkers. Thus, it is
imperative to verify that this variation is due to an underlying biological source instead of
artifacts induced by the algorithm, sample handling or data processing.
Scores
Scores produced by PCA and PLS are the observation rows of X projected onto a hyperplane
within the data that describes the covariances of X, or the covariances between X and Y,
respectively. In a nutshell, scores are good ‘summaries’ of the observations [35]. Because
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fewer predictive components are required to yield discrimination in OPLS-DA, two-class
scores plots are commonly built from one predictive component and one orthogonal
component. For PCA, class separations in scores are exposed only when within-class
variation is less than between-class variation. Because of this, misleading class separation in
a PCA scores plot is not a function of the algorithm, but occurs from sample preparation
problems [95], experimental bias [96], or inappropriate data preprocessing [82]. Contrary to
PCA, PLS and OPLS aggressively over-fit models to the data, almost always yielding scores
in which classes are separated [88]. As a result, PLS and OPLS can generate excellent class
separation even with random data (Figure 4) [86]. Thus, extreme care must be taken not to
infer model reliability from the existence of class separations in PLS or OPLS scores. In
effect, the use of PLS or OPLS models necessitates validation [97].
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For PCA and validated PLS scores, quantitative measures must be applied to reliably infer
significant separations between classes within a scores plot [98]. Simply, a visual inspection
of the clustering pattern or class separation in a scores plot is not typically sufficient to infer
statistical relevance. Methods using cluster overlap metrics [99], statistical distances [98],
and hierarchical clustering [100, 101] have been successfully used to quantify separations in
scores plots. Also, class membership may be inferred from 95% confidence ellipses
calculated from scores [101].
Loadings
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Loadings from PCA and (O)PLS are the directions of the hyperplane mentioned above with
respect to the original X variables, and function as good ‘summaries’ of the variables'
influence on the model. Due to the complementary nature of scores and loadings as
explanations of the rows and columns of X, respectively, the two may be used in concert.
Variables whose loadings are co-located away from the origin in a loadings plot may be
inferred to be correlated. Moreover, variables with loadings in a given position in a loadings
plot contribute heavily to observations whose scores are found in a similar position in a
scores plot. This requires proper normalization such that the scores and loadings are on the
same scale, where the loadings closest to the scores are expected to have the highest
contribution to class separation. The ease of interpretation of loadings is directly affected by
the number of variables and the scaling method used, if any [82]. As indicated by Table 1,
scaling protocols emphasize different spectral features which will then perturb the influence
of a particular variable on the model. In turn, the magnitude of the corresponding loadings
will be proportionally affected. As an example, Pareto scaling is commonly used to reduce
the influence of intense peaks while emphasizing weaker peaks that may have more
biological relevance. The corresponding loadings of intense peaks will be reduced and
loadings from weak peaks will be increased due to Pareto scaling.
Loadings may also be examined on a per-component basis as a line plot, with the loading
value plotted as dependent upon the spectral variables (ppm, m/z, v). This is especially
valuable when full-resolution spectra are used as data. In this form, the loadings of each
model component may be viewed as a spectrum or pseudo-spectrum, with large positive or
negative excursions of a variable's loading corresponding to a large positive or negative
correlation with class structure, respectively. With full-resolution spectra and OPLS-DA
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models, this method of interpreting loadings is highly useful for identifying metabolites
contributing to class differences [67, 102]. Pareto scaling has an added advantage in this
context, as it better preserves spectral lineshapes in loading pseudo-spectra. Of course, large
loadings corresponding to irrelevant spectral regions such as noise, artifacts, buffers, or
solvent peaks, raise serious concerns about the biological relevance of the model.
Weights
The weights produced in A by multivariate analysis are the relative degrees of influence that
each observed variable in X has on each of the latent structures in the model, and are used to
transform new observation vectors from later measurements into scores space for the
purposes of class prediction. A common misconception is misrepresenting loadings as
weights for the purposes of identifying variable or metabolite contribution to class
separation.
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Validation

Author Manuscript

PLS and OPLS have an innate tendency to over-fit models to data, even identifying
excellent class separation in completely random variables as demonstrated in Figure 4 [88].
For PLS and OPLS, validation is a critical step in ensuring model reliability. Truly honest
model validation requires partitioning the data into a training set used to build a model and a
validation set used to assess predictive ability of the model, where the validation set is in no
way used to generate the trained model [103, 104]. Few practitioners have adopted this
method of validation because of the low sample count in metabolic fingerprinting
experiments and the costly nature of sample preparation and data acquisition. Instead,
internal cross-validation is routinely employed, where the leave-one-out method is a
common choice [105]. However, it has been demonstrated that leave-one-out internal crossvalidation should be abandoned [106-108] in favor of the more consistent leave- n -out
method.
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In the leave- n -out method, the data is partitioned into
subsets, where each of the
subsets is then used as a validation set [109, 110]. As true leave- n -out cross-validation is
computationally inefficient, Monte Carlo cross-validation may be utilized to rapidly estimate
model prediction ability [111, 112]. The quality assessment (Q2) statistic is typically
reported as a result of cross-validation and provides a qualitative measure of consistency
between the predicted and original data. Even still, Q2 has no standard of comparison or
critical value for inferring significance, aside from its theoretical maximum of 1 or an
empirically inferred acceptable value of ≥ 0.4 for a biological model [88]. Unfortunately, an
invalid or irrelevant model is still capable of producing a large Q2 value, since consistent
cross-validation requires a systematic deletion of large portions of its dataset during training.
One solution recently demonstrated for metabolomics combines random permutation of
class labels, which requires no deletion of data, with internal leave- n -out cross-validation
[88]. The approach produces a distribution of Q2 values suitable for testing the null
hypothesis for a model's Q2. In essence, a reliable model should yield a significantly larger
Q2 value compared to Q2 values generated from random models using the same data set.
The technique is also valid for testing null hypotheses for the area under Receiver Operating
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Characteristic (ROC) curves (AUROC) statistic and misclassification count. Another
method, the CV-ANOVA, uses the cross-validated predictive residuals of a model as a basis
for hypothesis testing [97].
Also, while they are not strictly a cross validation measure, the R2 values of a given model
may be used to assess its degree of fit to the data [35, 44]. PCA decompositions will return
only R2X, the degree to which the principal components describe the observation data, and
PLS decompositions will return both R2X and R2Y. Due to its division of X into Xˆ and Xˆo,
OPLS splits R2X into R2Xp and R2Xo, the explained sum of squares of the Y -predictive and
Y -uncorrelated components of X, respectively. Highly disparate R2 and Q2 values (i.e. R2,
Q2) are an indicator of possible model over-fitting in supervised analyses.

Applications
Author Manuscript

Raman and NMR Fingerprinting of Rat Urine

Author Manuscript

The application of Raman spectroscopy to the study of metabolite fingerprints has occurred
only relatively recently compared with the more mature NMR and MS techniques [31]. A
comparative analysis demonstrates Raman spectroscopy offers complementary spectral
information to NMR [40]. In the study, three groups of rats were orally fed different triazole
fungicides, and a fourth group was fed only the drug carrier vehicle as a control. After five
days of exposure, urine was collected from the rats and subjected to both 1H NMR and
Raman spectroscopy. NMR spectra were acquired on a Varian Inova 800 spectrometer with
a spectral width of 12.5 ppm over 64k data points using a standard 1D pre-saturation pulse
sequence. Peaks corresponding to the solvent, urea and carrier vehicle were removed from
the spectra, which were then truncated to 0.5 – 9.5 ppm extents and integrated into 0.04
ppm-wide bins. The NMR bins were then mean-centered and Pareto scaled [82] prior to
PCA.

Author Manuscript

While collection and PCA of Raman spectra was performed in similar fashion to the NMR
data, several marked differences exist. First, samples for Raman analysis were subjected to
ultrafiltration to remove fluorescent biomacromolecules having molecular weights greater
than 500 Da. While the filtration step reduced biologically irrelevant chemical noise in the
collected spectra, the authors noted that the tricarboxylates citrate, trans-aconintate, and
oxoglutarate were significantly removed in the process. Raman spectra were then collected
with 785 nm laser excitation at ∼5 cm-1 resolution between ∼3280 – 95 cm-1. Unlike the
collected NMR spectra, Raman peaks showed no significant pH-dependent variation,
permitting the full spectral resolution to be used in PCA without binning or alignment.
Spectra of urea and sodium azide were subtracted from each spectrum, which were then
truncated to 1705 – 467 cm-1, mean-subtracted, normalized to constant AUC and submitted
to PCA and PLS-DA.
Figure 5 shows a comparison of the PCA scores produced by the collected NMR and Raman
datasets. From the scores, it can be seen that the within-class variation of the Raman spectra
is noticeably lower than that of the NMR spectra, effectively showing a better separation for
the collected samples. However, due to the low number of spectra collected for each
experimental class, it is difficult to judge class separations on a statistical basis. The authors
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note that PCA captured a greater percentage variance of the Raman spectra than the NMR
spectra, suggesting better performance. This use of captured variance is incorrect, however,
as captured variance is a relative measure that only describes model performance for any
given dataset and not between different datasets.

Author Manuscript

Finally, two-class PLS-DA was used to find loadings in the Raman spectra that
discriminated between each fungicide treatment and the control. Significant changes in the
loadings were found to coincide with transitions of the metabolites allantoin, creatine,
alanine, taurine, acetate and hippurate. However, no measures of validation were provided to
lend statistical credence to the observed metabolite changes. The class distinction present in
the PCA scores plot does suggest the same class separation in the PLS-DA is likely correct.
But, the PLS-DA model could still be over-fitted to the data, leading to an invalid model and
incorrect loadings. As a result, the identified metabolites could be biologically irrelevant.
This is not necessarily true, but it is plausible outcome in the absence of a validated PLS-DA
model. Nevertheless, the study does provide an illustrative proof-of-principle for Raman
spectroscopy-based metabolic fingerprinting which, with further tuning, promises to be a
useful instrumental platform for metabolomics.
Discrimination of French Labeled Brandies

Author Manuscript

While the metabolite profiles of many brandies were previously known, marker metabolites
that could be used to discriminate between different types of brandy were not identified.
Such metabolites could be used in determination of the origin and authenticity of French
labeled brandies. To that end, gas chromatography mass spectrometry (GC-MS) analyses of
Cognac, Armagnac, Calvados and Mirabelle were analyzed and subjected to PLS-DA [113].
Ethyl undecanoate and 4-methylpentan-2-ol were added to the brandy samples for use as
internal standards, and two liquid-liquid extractions were used to isolate the volatile organic
molecules from the samples.
Peaks in the collected GC-MS spectra having a signal-to-noise greater than 10 were linked
with compounds using database searches based on electron impact spectra and retention
indices; the resulting intensities of all compounds were then normalized to the internal
standards. The data matrix was then generated using the calculated relative compound
concentrations, which were mean-centered and autoscaled to unit variance prior to PLS-DA.
This particular study highlights the flexibility of multivariate analysis methods to accept any
type of variable, not only raw spectral information, for modeling purposes in metabolomics.

Author Manuscript

Figure 6 shows the variable loadings from PLS-DA plotted for the two discriminatory
components found in the GC-MS dataset. The authors understandably described the loadings
as weights in the manuscript, a confusing description exacerbated by the SIMCA
(UMETRICS) nomenclature for PLS loadings (w*C[n]). Unfortunately, the SIMCA
loadings nomenclature appears startlingly similar to the PLS regression coefficients [35], the
product of X -weights and Y -weights, and not the loadings. However, in PLS loading plots
of this type, the X -weights (w*) and Y -weights (C) are simply plotted together – not
multiplied – in order to expose the correlation structure between X and Y. The loadings for
each type of brandy in scores space were printed on the loadings plot to aid in identifying
compounds that contribute most to the discrimination between each of the beverage types.
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Importantly, loadings must be non-zero along any principal component axis to have any
contribution to the model.
Each loading is correlated to a particular X -variable, in this case the molecular-weight of a
particular metabolite. Thus, the loadings strongly correlated with scores for each type of
brandy identify metabolites that may uniquely describe or characterize that particular
brandy. While the volatile compound identification and quantification procedure resulted in
a great wealth of useful information, no validation statistics were provided to justify the
discriminatory compounds selected from the PLS-DA loadings. Again, the lack of
appropriate validation is a common problem among the metabolomics community.
Correlations of Human Gut Microbiome with Urine Metabolites

Author Manuscript

Studies have shown that the microbiome – the sum total of all microbial organisms – of the
human gastrointestinal tract has a great impact on individual metabolite profiles, even when
genetic variations are minimized [114]. Changes in the symbiotic gut microbes correlate
with phenotypic variations observed between gender and across ethnicities, and are
implicated in many forms of human pathology. Recent work based on the gut microbiomes
and urine metabolic fingerprints of Chinese family members has shed light onto correlations
between gut flora and phenotype [45].

Author Manuscript

In the study by Li et al., selected portions of the bacterial genomes of family members' gut
microbiota were subjected to denaturing gradient gel electrophoresis (DGGE), and urine
samples were also collected from each family member and analyzed by 1H NMR
spectroscopy. OPLS-DA was used to identify gender-predictive components of the DGGE
gels and NMR spectra. The Q2 value of each variable obtained by five-fold internal crossvalidation was used to identify statistically reliable loadings in the OPLS-DA models.
Species of Clostridia, Bacteroidetes and Proteobacteria were found to be predictive of
gender based on DGGE gels, and 3-aminoisobutyrate and creatine were found to predict
gender from the NMR spectra.

Author Manuscript

A cross-correlation analysis was also performed to model the DGGE gel bands using NMR
spectral data, and vice versa, using OPLS regression. Again, five-fold internal crossvalidation was performed to ensure model reliability, and the predictions of NMR peaks and
DGGE bands made by the model were color-coded according to Q2 to facilitate rapid
identification of significant correlations. A correlation matrix was also constructed to show
peaks in the collected NMR spectra that co-varied with bands in the DGGE gel. Figure 7
summarizes the results of the cross-correlation analysis. This study highlights a powerful use
of OPLS, both in discrimination and regression applications, as well as the use of crossvalidation statistics.
Analysis of Bacterial Metabolic Signaling of Stress Response
It has been shown that the stress response of prokaryotic organisms contains a metabolic
sensing component, centered around the tricarboxylic acid (TCA) cycle and sensed by
catabolite control protein A (CcpA), that effects downstream signaling networks involved in
virulence factor presentation and biofilm formation [115]. Metabolic fingerprinting using 1H
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NMR spectroscopy was conducted to further examine the effects of external biofilminducing perturbations on the metabolome of Staphylococcus epidermidis [116]. Metabolite
mixtures were collected from wild-type cells, as well as cells exposed to sodium chloride,
glucose, tetracycline, ethanol, iron-depleted media, and an aconitase deletion mutation.

Author Manuscript

PCA analysis of the NMR spectra revealed that the sodium chloride-treated cells grouped
with the wild-type in scores space. All other observations on treated cells group together in
scores space except for glucose treatment, which clustered separately from all observations.
The separations between classes in the PCA scores were used to define two classes for a
subsequent OPLS-DA analysis, with wild-type and salt-treated cells discriminated from all
other observations. Figure 8 shows the OPLS scores plot and dendrogram resulting from
decomposition into one Y -predictive component and three Y -uncorrelated components. In
the OPLS model, the explained sum of squares for X and Y were found to be 0.637 and
0.966, respectively. It is important to note that the reported R2X of 0.637 includes Y uncorrelated variation, and is therefore not a measure of modeled predictive variation.
Leave- n -out internal cross-validation resulted in a Q2 value of 0.941, an acceptable value in
light of the models R2Y, but by no means conclusive. While it was not performed for the
publication, a subsequent validation using CV-ANOVA provided a p -value of 0.0 – to
within machine precision [117] – for the OPLS model.
Future Directions

Author Manuscript

Multivariate analysis of metabolic fingerprinting datasets is performed most often with the
linear projection-based methods of PCA, PLS and OPLS, but these are by no means the only
tools available. Hierarchical clustering analysis (HCA) and nearest-neighbor clustering may
be applied to multivariate spectral data to reveal differences between classes without
supervision. Support-vector machine (SVM) methods [118] have been applied to human
urine metabolomics NMR [119], NIR and UV datasets [120] with enhanced predictive
power over PLS-DA. Artificial neural networks (ANN) have also been used in combination
with PCA for plant metabolic profiling and fingerprinting [121, 122]. In contrast to pure
PCA and PLS, which model linear relationships, both SVM and ANN algorithms admit the
use of a kernel function to allow for modeling of non-linear relationships between X and Y.
However, none of these methods provide quite the interpretative simplicity of projective
‘latent-space’ methods such as PCA and PLS. The metabolomics community is accustomed
to drawing conclusions from PCA and PLS results, but these new methods with their
unfamiliar analysis formats require further acclimation.

Author Manuscript

Finally, the majority of multivariate analysis techniques used in metabolic fingerprinting are
designed for ‘snapshot’ datasets, where the state of a system is observed at one or two highly
distinct time points. However, as instrumental methods improve to accommodate
measurement of highly time-resolved metabolite concentration changes, methods of
multivariate analysis must be developed to cope with the new information [123]. Multi-way
data analysis methods such as Parallel Factor Analysis (PARAFAC [124]), consensus PCA
(CPCA) and multi-block PLS are all suited to particular types of multi-way datasets [125].
Somewhat similar in form to time-resolved metabolomic datasets are those produced by the
fusion of data from orthogonal or complementary instrumentation. For example, 1H NMR
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Concluding Remarks

Author Manuscript

and LC-MS data matrices have been combined by multiple means to achieve improved PCA
and PLS models [126]. GC-MS and LC-MS datasets [127], as well as near-IR and mid-IR
spectral datasets [128] have been similarly fused for the purposes of multivariate analysis.
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Figure 1.

Canonical example of the data (X) and response (Y) matrices and decompositions thereof
used by projection-based multivariate analysis algorithms. In metabolic fingerprinting
applications, the data matrix will contain spectral information on its rows, such that every
column will represent a single spectral frequency or bin. For supervised projections, each
row of data is paired with a corresponding row in the response matrix that holds either
continuously varying outputs or binary (n -ary) class memberships. The data is then
decomposed into a small number of score vectors (t) and loading vectors(p), with a
corresponding weight vector (w) used to transform rows of X to scores space. Responses are
similarly decomposed into scores (u) and loadings (C), where t is an effective estimator of u.
Adapted with permission from reference [35], (Copyright 2001 Elsevier).
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Figure 2.

Example of the use of binning on a 1H NMR spectrum of a rat urine sample, with a bin
spectral width of 0.04 ppm. In this example, binning reduces the number of data variables
from 65,536 to 312, facilitating multivariate analysis by PCA and PLS-DA. Reprinted with
permission from reference [40], (Copyright 2007 American Chemical Society).
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Figure 3.

Demonstration of the effects of autoscaling to unit variance in simulated 1H NMR spectral
data. (A) Set of 40 spectra containing two Lorentzian peaks having random intensities,
summed with Gaussian baseline noise. (B) Spectra from above with mean-centering. (C)
Spectra with mean-centering and autoscaling to unit variance, exhibiting amplification of
noise in signal-free regions. Adapted with permission from reference [80], (Copyright 2006
American Chemical Society).
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Figure 4.

Scores from the PLS-DA discrimination of 1H NMR spectra from 23 healthy volunteers,
where class labels have been randomly assigned. Internal cross-validation produces a Q2 of
-0.18, clearly well below acceptable limits. Nevertheless, the scores plot displays a clear
separation between classes that could lead the inexperienced practitioner to wholly false
biological conclusions. Reprinted with permission from reference [88], (Copyright 2008
Westerhuis et. al.).
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Figure 5.

Scores from PCA decomposition of (A) 1H NMR and (B) Raman spectra of rat urine
metabolites, demonstrating the use of PCA to compare within- and between-group variation
datasets from complementary instrumental sources. In this example, the captured variances
on each plot reflect the relative effectiveness of PCA to approximate the input data, and may
not be used as a standard of comparison. Reprinted with permission from reference [40],
(Copyright 2007 American Chemical Society).
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Figure 6.

PLS-DA loadings for volatile compound composition of French labeled brandies. Clustering
patterns of variables reveal relevance of those X variables to the responses in Y. The Y weights for each type of brandy are labeled and represented as squares, and the X -weights
are represented as numbered triangles. Variable numbers relate to volatile compounds
identified by GC-MS analysis, with the identity and amount of each compound may be
found in reference [113]. Reprinted with permission from reference [113], (Copyright 2010
American Chemical Society).
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Figure 7.

Cross-correlation analysis between the DGGE gel in (A) and collected 1H NMR spectra of
urine metabolites. (B) Prediction of DGGE bands using NMR spectra. (C) Correlation
matrix relating the aromatic region of collected NMR spectra to DGGE bands. Red indicates
positive correlation greater than 0.7 and blue indicates negative correlation of the same
magnitude or greater. (D) Prediction of the NMR spectral aromatic region based on DGGE
data. Both predictions from OPLS regression are colored according to Q2 obtained from
cross-validation. Reprinted with permission from reference [45], (Copyright 2008 National
Academy of Sciences of the USA).
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Results of OPLS-DA modeling of the metabolomic effects of six different stressors on S.
epidermidis. (A) OPLS scores of all experimental groups, showing the high observation
counts for each group necessary for statistical treatment of scores. Ellipses around each
group the 95% confidence regions of the groups under the assumption of normally
distributed data. (B) Dendrogram built from OPLS scores-space data using Euclidean
distances between the sample means of each group. Within-group substructure that was not
forced during class discrimination is evident in the dendrogram. Group name colors in (B)
correspond to scores colors in (A). Reprinted with permission from reference [116],
(Copyright 2011 American Chemical Society).
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Listing of most commonly used data scaling methods in metabolic fingerprinting multivariate analyses.1
Method

Equation

Centering

∼
x ik = xik − x̄ k

UV

xik − x̄ k
∼
x ik =
sk
Range

Author Manuscript

xik − x̄ k
∼
x ik =
x
−x
k,max
k ,min
Pareto

xik − x̄ k
∼
x ik =
sk
Vast

xik − x̄ k
∼
x ik =
C
sk
Level

Author Manuscript

xik − x̄ k
∼
x ik =
x̄ k

Goal

Advantage

Disadvantage

Focus on differences, not
similarities

Removes offset from the data

Unsuitable for heteroscedastic
data

Compare metabolites based
on correlation

All metabolites equally
important

Inflation of measurement errors

Compare metabolites relative
to biological response range

All metabolites equally
important. Biologically related
scaling

Inflation of measurement errors,
sensitive to outliers

Reduce relative importance of
large values, partially
preserve data structure

Stays closer to original
measurement than UV

Sensitive to large fold changes

Focus on small fluctuations

Aims for robustness, uses prior
group knowledge

Not suited for large induced
variation without group structure

Focus on relative response

Suited for biomarker
identification

Inflation of measurement errors

x̄ k
sk

1

Variable subscripts reflect conventions shown in Figure 1, with the mean of the k -th variable in X represented by x̄k and its deviation represented

by sk, the sample standard deviation. Reprinted with permission from reference [82], (Copyright 2006 van den Berg et. al.).
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